Owens & Minor, Inc. (NYSE:OMI) Receives $12.50 Average Price Target from Analysts

Owens & Minor, Inc. (NYSE:OMI - Get Free Report) has received an average rating of "Hold" from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $12.50.

Several equities analysts have weighed in on the company. JPMorgan Chase & Co. dropped their price objective on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a report on Monday, March 10th. UBS Group dropped their price target on Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Citigroup cut their price objective on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, April 17th. Finally, Robert W. Baird raised their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a report on Monday, March 3rd.

Owens & Minor Stock Performance

NYSE:OMI traded down $0.06 during mid-day trading on Friday, reaching $6.91. 980,968 shares of the company's stock were exchanged, compared to its average volume of 1,114,737. Owens & Minor has a one year low of $6.07 and a one year high of $25.60. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The business's fifty day simple moving average is $8.18 and its two-hundred day simple moving average is $11.24. The firm has a market capitalization of $533.83 million, a PE ratio of -10.63, a price-to-earnings-growth ratio of 0.20 and a beta of 1.02.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its earnings results on Friday, February 28th. The company reported $0.55 EPS for the quarter, topping the consensus estimate of $0.53 by $0.02. The company had revenue of $2.70 billion for the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business's revenue for the quarter was up 1.5% on a year-over-year basis. During the same period last year, the firm earned $0.69 earnings per share. Analysts anticipate that Owens & Minor will post 1.51 earnings per share for the current fiscal year.

Owens & Minor declared that its board has approved a share repurchase program on Friday, February 28th that authorizes the company to repurchase $100.00 million in shares. This repurchase authorization authorizes the company to reacquire up to 13.6% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's management believes its shares are undervalued.

Insider Transactions at Owens & Minor

In other news, major shareholder Coliseum Capital Management, L purchased 1,738,511 shares of the company's stock in a transaction dated Friday, February 28th. The stock was bought at an average cost of $9.39 per share, for a total transaction of $16,324,618.29. Following the purchase, the insider now owns 9,469,698 shares of the company's stock, valued at approximately $88,920,464.22. The trade was a 22.49 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last 90 days, insiders purchased 2,718,412 shares of company stock valued at $24,495,308. 3.69% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently bought and sold shares of OMI. Waldron Private Wealth LLC bought a new stake in shares of Owens & Minor during the fourth quarter worth about $406,000. JPMorgan Chase & Co. boosted its position in Owens & Minor by 68.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company's stock worth $5,912,000 after buying an additional 152,999 shares during the period. Advisors Preferred LLC grew its holdings in Owens & Minor by 173.9% during the 4th quarter. Advisors Preferred LLC now owns 84,305 shares of the company's stock worth $1,083,000 after acquiring an additional 53,529 shares during the last quarter. Barclays PLC increased its position in Owens & Minor by 354.8% in the 3rd quarter. Barclays PLC now owns 133,702 shares of the company's stock valued at $2,099,000 after acquiring an additional 104,305 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Owens & Minor by 6.0% in the 4th quarter. Bank of New York Mellon Corp now owns 622,921 shares of the company's stock valued at $8,142,000 after acquiring an additional 35,105 shares during the period. Institutional investors own 98.04% of the company's stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.